P. Vranckx

发表

DAPT Score and the Impact of Ticagrelor Monotherapy During the Second Year After PCI.

P. Serruys, H. Suryapranata, J. Wykrzykowska, 2020, JACC. Cardiovascular interventions.

Standardized Bleeding Definitions for Cardiovascular Clinical Trials: A Consensus Report From the Bleeding Academic Research Consortium

Marco Valgimigli, Pascal Vranckx, Mitchell W Krucoff, 2011, Circulation.

Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting: A Randomized Multicenter Trial

J. Marchesini, R. Ferrari, M. Valgimigli, 2012, Circulation.

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).

Marco Valgimigli, Marco Roffi, Pascal Vranckx, 2018, European heart journal.

Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER Trial.

C. Held, P. Armstrong, F. Van de Werf, 2016, Journal of the American College of Cardiology.

Ticagrelor Monotherapy Beyond One Month after PCI in ACS or Stable CAD in Elderly Patients Aged Above 75 Years: a Prespecified Analysis of the Randomized GLOBAL LEADERS Trial.

P. Serruys, J. Tijssen, P. Jüni, 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Third universal definition of myocardial infarction.

Jeroen J. Bax, P. Kirchhof, D. Atar, 2012, Global heart.

Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium.

Pascal Vranckx, Patrick W Serruys, Mitchell W Krucoff, 2011, Journal of the American College of Cardiology.

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.

Pascal Vranckx, Susheel Kodali, Patrick W Serruys, 2012, Journal of the American College of Cardiology.

Incidence, correlates, and significance of abnormal cardiac enzyme rises in patients treated with surgical or percutaneous based revascularisation: a substudy from the Synergy between Percutaneous Coronary Interventions with Taxus and Cardiac Surgery (SYNTAX) Trial.

M. Mack, P. Serruys, F. Mohr, 2013, International journal of cardiology.

Clinical development of bivalirudin (Angiox®): rationale for thrombin‐specific anticoagulation in percutaneous coronary intervention and acute coronary syndromes

P. Serruys, P. Serruys, P. Vranckx, 2006, International journal of clinical practice.

Safety and Efficacy of Double Antithrombotic Therapy With Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta‐Analysis

Deepak L. Bhatt, A. Goette, R. Mehran, 2020, Journal of the American Heart Association.

Standardization of Fractional Flow Reserve Measurements.

Pascal Vranckx, Mariano Pellicano, Emanuele Barbato, 2016, Journal of the American College of Cardiology.

Coronary Pressure–Derived Fractional Flow Reserve Measurements: Recommendations for Standardization, Recording, and Reporting as a Core Laboratory Technique. Proposals for Integration in Clinical Trials

M. Kern, R. Mehran, O. Muller, 2012, Circulation. Cardiovascular interventions.

Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review.

Deepak L. Bhatt, B. Gersh, C. Cannon, 2019, Journal of the American College of Cardiology.

Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non-ST-segment elevation acute coronary syndrome, and ST-segment elevation myocardial infarction.

P. Serruys, L. Räber, S. Silber, 2016, American heart journal.

Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes: A Post Hoc Analysis of the Randomized GLOBAL LEADERS Trial.

Deepak L. Bhatt, P. Serruys, G. Dangas, 2019, JAMA cardiology.

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation – Web Addenda

G. Hindricks, F. Crea, A. Kastrati, 2017 .

A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement.

J. Tijssen, G. Dangas, S. Windecker, 2019, The New England journal of medicine.

Thrombo-embolic prevention after transcatheter aortic valve implantation

G. Dangas, S. Windecker, R. Mehran, 2017, European heart journal.

Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY (Prolonging Dual-Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) t

M. Valgimigli, P. Calabrò, P. Vranckx, 2015, European heart journal.

The association of body mass index with long-term clinical outcomes after ticagrelor monotherapy following abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a prespecified sub-analysis of the GLOBAL LEADERS Trial

P. Serruys, H. Suryapranata, J. Wykrzykowska, 2020, Clinical Research in Cardiology.

Safety and Efficacy of 1-Month Dual Antiplatelet Therapy (Ticagrelor + Aspirin) Followed by 23-Month Ticagrelor Monotherapy in Patients Undergoing Staged Percutaneous Coronary Intervention (A Sub-Study from GLOBAL LEADERS).

P. Serruys, H. Suryapranata, R. D. de Winter, 2020, The American journal of cardiology.

Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Multivessel PCI.

P. Serruys, J. Tijssen, R. D. de Winter, 2019, Journal of the American College of Cardiology.

Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial.

P. Serruys, R. D. de Winter, J. Wykrzykowska, 2019, European heart journal.

Atrial fibrillation patients undergoing percutaneous coronary intervention: dual or triple antithrombotic therapy with non-vitamin K antagonist oral anticoagulants

A. Goette, P. Vranckx, 2020, European heart journal supplements : journal of the European Society of Cardiology.

Edoxaban Versus standard of care and their effects on clinical outcomes in patients having undergone Transcatheter Aortic Valve Implantation in Atrial Fibrillation—Rationale and design of the ENVISAGE‐TAVI AF trial

C. Hengstenberg, S. Saito, G. Dangas, 2018, American heart journal.

Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study

J. Tijssen, G. Dangas, S. Windecker, 2017, American heart journal.

Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial

A. Goette, L. Eckardt, J. Tijssen, 2019, The Lancet.

Defining Staged Procedures for Percutaneous Coronary Intervention Trials: A Guidance Document.

P. Serruys, G. Stone, H. Garcia-Garcia, 2018, JACC. Cardiovascular interventions.

Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates.

M. Valgimigli, M. Roffi, C. Briguori, 2015, Journal of the American College of Cardiology.

Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting

A. Íñiguez, P. Jüni, S. Windecker, 2021, Circulation.

Optimal Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: An Updated Network Meta-analysis.

Deepak L. Bhatt, A. Goette, C. Cannon, 2020, JAMA cardiology.

Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC).

Eld, K. Rosen, M. Krucoff, 2015, Journal of the American College of Cardiology.

Evaluation and Treatment of Patients With Lower Extremity Peripheral Artery€Disease

Wiechmann, M. Krucoff, W. Gray, 2015 .

Clinical introduction of the Tandemheart, a percutaneous left ventricular assist device, for circulatory support during high-risk percutaneous coronary intervention

P. Serruys, D. Foley, J. Vos, 2003, International journal of cardiovascular interventions.

Identifying stent thrombosis, a critical appraisal of the academic research consortium (ARC) consensus definitions: a lighthouse and as a toe in the water.

P. Serruys, D. Cutlip, P. Vranckx, 2008, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

The Radial Artery for Percutaneous Coronary Procedures or Surgery?

Sunil V. Rao, F. Burzotta, C. Trani, 2018, Journal of the American College of Cardiology.

Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes.

P. Jüni, M. Valgimigli, A. Santarelli, 2015, The New England journal of medicine.

Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial

Sunil V. Rao, P. Jüni, M. Valgimigli, 2015, The Lancet.

Impact of Bleeding and Myocardial Infarction on Mortality in All-Comer Patients Undergoing Percutaneous Coronary Intervention

P. Serruys, R. D. de Winter, J. Wykrzykowska, 2020, Circulation. Cardiovascular interventions.

Peri-procedural use of rivaroxaban in elective percutaneous coronary intervention to treat stable coronary artery disease

R. D. de Winter, M. van Eickels, F. Verheugt, 2015, Thrombosis and Haemostasis.

Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: impact on outcome reporting

P. Serruys, G. Stone, S. Silber, 2012, Heart.

P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials

P. Serruys, P. Jüni, G. Dangas, 2021, BMJ.

Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial

P. Serruys, S. Garg, S. Windecker, 2020, Cardiovascular Diabetology.

Usefulness of the updated logistic clinical SYNTAX score after percutaneous coronary intervention in patients with prior coronary artery bypass graft surgery: Insights from the GLOBAL LEADERS trial

P. Serruys, P. Jüni, S. Garg, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Efficacy and safety of one-month DAPT followed by 23-month ticagrelor monotherapy in patients undergoing proximal LAD stenting: Insights from the GLOBAL LEADERS trial.

P. Serruys, R. D. de Winter, J. Wykrzykowska, 2020, International journal of cardiology.

Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment–Elevation Myocardial Infarction

S. Windecker, M. Valgimigli, R. Piccolo, 2020, Circulation.

Safety and efficacy of double vs. triple antithrombotic therapy in patients with atrial fibrillation with or without acute coronary syndrome undergoing percutaneous coronary intervention: a collaborative meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials

A. Goette, C. Cannon, S. Windecker, 2020, European heart journal. Cardiovascular pharmacotherapy.

Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology

C. Granger, H. Thiele, D. Zahger, 2020, European heart journal. Acute cardiovascular care.

Impact of angiographic coronary artery disease complexity on ischemic and bleeding risks and on the comparative effectiveness of zotarolimus-eluting vs. bare-metal stents in uncertain drug-eluting stent candidates.

S. Windecker, M. Valgimigli, M. Roffi, 2019, International journal of cardiology.

Clinical relevance of ticagrelor monotherapy following 1‐month dual antiplatelet therapy after bifurcation percutaneous coronary intervention: Insight from GLOBAL LEADERS trial

P. Serruys, P. Jüni, S. Garg, 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Long-term ticagrelor monotherapy versus standard dual antiplatelet therapy followed by aspirin monotherapy in patients undergoing biolimus-eluting stent implantation: rationale and design of the GLOBAL LEADERS trial.

P. Serruys, P. Jüni, S. Windecker, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

4-year clinical outcomes and predictors of repeat revascularization in patients treated with new-generation drug-eluting stents: a report from the RESOLUTE All-Comers trial (A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention

P. Serruys, S. Silber, S. Windecker, 2014, Journal of the American College of Cardiology.

Interventional Cardiology 4-Year Clinical Outcomes and Predictors of Repeat Revascularization in Patients Treated With New-Generation Drug-Eluting Stents A Report From the RESOLUTE All-Comers Trial ( A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutan

P. Serruys, S. Silber, S. Windecker, 2022 .

[Fourth universal definition of myocardial infarction (2018)].

Jeroen J. Bax, D. Atar, E. Antman, 2018, Kardiologia polska.

Application of the MADS classification system in a “mega mammoth” stent trial: Feasibility and preliminary clinical implications

P. Serruys, S. Windecker, M. Valgimigli, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC).

M. Krucoff, W. Gray, Manesh R Patel, 2015, Journal of the American College of Cardiology.

Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting.

P. Serruys, P. Jüni, S. Garg, 2019, Journal of the American College of Cardiology.

Association of Pulse Pressure With Clinical Outcomes in Patients Under Different Antiplatelet Strategies After Percutaneous Coronary Intervention: Analysis of GLOBAL LEADERS.

P. Serruys, J. Wykrzykowska, S. Garg, 2019, The Canadian journal of cardiology.

Autopsy validation study of the academic research consortium stent thrombosis definition.

R. Virmani, A. Finn, M. Krucoff, 2011, JACC. Cardiovascular interventions.

Design and Rationale of the Swiss-Apero Randomized Clinical Trial: Comparison of Amplatzer Amulet vs Watchman Device in Patients Undergoing Left Atrial Appendage Closure

A. Huber, L. Räber, S. Windecker, 2021, Journal of Cardiovascular Translational Research.

Use of Impella Recover(R) LP 2.5 left ventricular assist device during high-risk percutaneous coronary interventions; clinical, haemodynamic and biochemical findings.

P. Serruys, M. Valgimigli, P. Steendijk, 2006, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Use of endpoint adjudication to improve the quality and validity of endpoint assessment for medical device development and post marketing evaluation: Rationale and best practices. A report from the cardiac safety research consortium

Jonathan H Seltzer, D. Cutlip, P. Vranckx, 2017, American heart journal.

Post-Procedural Bivalirudin Infusion at Full or Low Regimen in Patients With Acute Coronary Syndrome.

S. Windecker, M. Valgimigli, A. Santarelli, 2019, Journal of the American College of Cardiology.

A randomised study of dabigatran in elective percutaneous coronary intervention in stable coronary artery disease patients.

E. Regar, P. Smits, F. Verheugt, 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Does the site of bleeding matter? A stratified analysis on location of TIMI-graded bleedings and their impact on 12-month outcome in patients with ST-segment elevation myocardial infarction.

G. Biondi-Zoccai, F. Prati, R. Ferrari, 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Looking back into the future: desirudin in acute coronary syndromes and coronary stenting.

P. Serruys, M. Valgimigli, P. Vranckx, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

SINUS BRADYCARDIA AS THE INITIAL MANIFESTATION OF COVID-19

S. Windecker, M. Valgimigli, G. Esposito, 2021, Journal of the American College of Cardiology.

Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI.

Deepak L. Bhatt, S. Saito, H. Thiele, 2021, Journal of the American College of Cardiology.

Implementation of reperfusion therapy in ST-segment elevation myocardial infarction A policy statement from the Belgian Society of Cardiology (BSC), the Belgian Interdisciplinary Working Group on Acute Cardiology (BIWAC) and the Belgian Working Group on Interven-tional Cardiology (BWGIC)

F. Van de Werf, W. Desmet, C. Vrints, 2009, Acta cardiologica.

Two-by-two factorial comparison of high-bolus-dose tirofiban followed by standard infusion versus abciximab and sirolimus-eluting versus bare-metal stent implantation in patients with acute myocardial infarction: design and rationale for the MULTI-STRATEGY trial.

F. Prati, R. Ferrari, M. Valgimigli, 2007, American heart journal.

Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis.

Samin K. Sharma, S. Pocock, P. Serruys, 2021, JACC. Cardiovascular interventions.

Patients With Atrial Fibrillation and PCI or ACS: Does Predicted Risk Matter?

M. Valgimigli, D. Angiolillo, P. Vranckx, 2022, Journal of the American College of Cardiology.

Clinical risk predictors in atrial fibrillation patients following successful coronary stenting: ENTRUST-AF PCI sub-analysis

A. Goette, L. Eckardt, J. Tijssen, 2020, Clinical Research in Cardiology.

Impact of recruitment and retention on all-cause mortality in a large all-comers randomised controlled trial: insights from the GLOBAL LEADERS trial

P. Serruys, R. D. de Winter, J. Wykrzykowska, 2019, Clinical Research in Cardiology.

Short- versus long-term duration of dual antiplatelet therapy in patients treated for in-stent restenosis: a PRODIGY trial substudy (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia).

R. Ferrari, M. Valgimigli, G. Campo, 2014, Journal of the American College of Cardiology.

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2).

M. Mack, P. Serruys, A. Kirtane, 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary intervention

Deepak L. Bhatt, Sunil V. Rao, P. Serruys, 2022, Nature Reviews Cardiology.

Aspirin-free antiplatelet regimens after PCI: insights from the GLOBAL LEADERS trial and beyond

P. Serruys, S. Garg, S. Windecker, 2021, European heart journal. Cardiovascular pharmacotherapy.

‘Ticagrelor alone vs. dual antiplatelet therapy from 1 month after drug-eluting coronary stenting among patients with STEMI’: a post hoc analysis of the randomized GLOBAL LEADERS trial

P. Serruys, P. Jüni, S. Windecker, 2021, European heart journal. Acute cardiovascular care.

Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX.

S. de Servi, P. Jüni, S. Windecker, 2017, Journal of the American College of Cardiology.

Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial

A. Goette, L. Eckardt, J. Tijssen, 2020, European heart journal.

Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.

Dick M. Goedhart, P. Serruys, K. Kuck, 2010, Journal of the American College of Cardiology.

Impact of renal function on clinical outcomes after PCI in ACS and stable CAD patients treated with ticagrelor: a prespecified analysis of the GLOBAL LEADERS randomized clinical trial

P. Serruys, S. Garg, S. Windecker, 2020, Clinical Research in Cardiology.

Intensive and acute cardiovascular care: an introduction

C. Vrints, P. Vranckx, M. Tubaro, 2021 .

Anticoagulation for Percutaneous Ventricular Assist Device-Supported Cardiogenic Shock: JACC Review Topic of the Week.

G. Stone, S. Janssens, P. Vranckx, 2022, Journal of the American College of Cardiology.

Clinical outcome of patients with stable ischaemic heart disease as compared to those with acute coronary syndromes after percutaneous coronary intervention.

P. Serruys, S. Silber, P. Jüni, 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Impact of Sex on Comparative Outcomes of Radial Versus Femoral Access in Patients With Acute Coronary Syndromes Undergoing Invasive Management: Data From the Randomized MATRIX-Access Trial.

S. Windecker, M. Valgimigli, A. Santarelli, 2018, JACC. Cardiovascular interventions.

Quality assessment in Belgian ST elevation myocardial infarction patients: results from the Belgian STEMI database

P. Sinnaeve, P. Vranckx, M. Claeys, 2018, Acta cardiologica.

Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial.

S. Windecker, M. Valgimigli, G. Esposito, 2016, American heart journal.

Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6-month or 24-month DAPT duration : insights from the PRODIGY trial

S. Windecker, M. Valgimigli, G. Esposito, 2016 .

Darapladib effect on circulating high sensitive troponin in patients with acute coronary syndromes.

P. Serruys, H. Garcia-Garcia, E. Boersma, 2012, Atherosclerosis.

Choice of access site and type of anticoagulant in acute coronary syndromes with advanced Killip class or out-of-hospital cardiac arrest.

S. Windecker, M. Valgimigli, G. Esposito, 2020, Revista espanola de cardiologia.

The TandemHeart, percutaneous transseptal left ventricular assist device: a safeguard in high-risk percutaneous coronary interventions. The six-year Rotterdam experience.

P. Serruys, E. Regar, P. Vranckx, 2008, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part€2: Endpoint Definitions

D. Adams, G. Stone, K. Kuck, 2017 .

Integrating the results of the CULPRIT-SHOCK trial in the 2017 ESC ST-elevation myocardial infarction guidelines: viewpoint of the task force

H. Thiele, F. Neumann, S. Windecker, 2018, European heart journal.

Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel (3T/2R). Rationale for the Study and Protocol Design

R. Ferrari, M. Valgimigli, G. Campo, 2008, Cardiovascular Drugs and Therapy.

Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial

P. Serruys, S. Garg, S. Windecker, 2020, Cardiovascular Diabetology.

Bivalirudin or Heparin in Patients Undergoing Invasive Management of Acute Coronary Syndromes.

S. Windecker, M. Valgimigli, A. Santarelli, 2018, Journal of the American College of Cardiology.

Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial

E. Bramucci, E. D. Lorenzo, E. Romagnoli, 2018, The Lancet.

Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome).

C. Held, P. Armstrong, F. Van de Werf, 2014, Journal of the American College of Cardiology.

Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity. Addendum to the historical MI definitions used in stent studies.

P. Serruys, S. Silber, S. Windecker, 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Echocardiography remains the standard for the diagnostic evaluation of left ventricular tumors: a case report with anatomical correlation.

P. Dendale, P. Vranckx, M. Hendrikx, 2007, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

Effects of pre‐hospital clopidogrel administration on early and late residual platelet reactivity in ST‐segment elevation myocardial infarction patients undergoing primary intervention

M. Valgimigli, G. Campo, P. Vranckx, 2013, Journal of thrombosis and haemostasis : JTH.

Randomized comparison of Zotarolimus-Eluting Endeavor Sprint versus bare-metal stent implantation in uncertain drug-eluting stent candidates: rationale, design, and characterization of the patient population for the Zotarolimus-eluting Endeavor Sprint stent in uncertain DES candidates study.

Marco Valgimigli, Athanasios Patialiakas, Attila Thury, 2013, American heart journal.

Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) Study

A. Íñiguez, J. Tijssen, P. Jüni, 2019, American heart journal.

Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials

A. Goette, L. Eckardt, M. Valgimigli, 2019 .

Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevation

P. Jüni, S. Windecker, M. Valgimigli, 2017, European heart journal.

Giant left main coronary artery aneurysm in association with severe atherosclerotic coronary disease.

P. Vranckx, L. Pirót, E. Benit, 1997, Catheterization and cardiovascular diagnosis.

Clinical event committees in coronary stent trials: insights and recommendations based on experience in an unselected study population.

R. Mehran, D. Cutlip, P. Vranckx, 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Clinical endpoint adjudication in a contemporary all-comers coronary stent investigation: methodology and external validation.

P. Serruys, S. Silber, S. Windecker, 2013, Contemporary Clinical Trials.

Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trial

J. J. Piek, Deepak L. Bhatt, P. Serruys, 2022, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Antithrombotic treatment strategies after PCI – Authors' reply

A. Goette, L. Eckardt, M. Valgimigli, 2020, The Lancet.

Does smoking habit affect the randomized comparison of 6 versus 24-month dual antiplatelet therapy duration? Insights from the PRODIGY trial.

H. Garcia-Garcia, M. Valgimigli, P. Vranckx, 2015, International journal of cardiology.

Impact of Medication Nonadherence in a Clinical Trial of Dual Antiplatelet Therapy.

S. Windecker, M. Valgimigli, P. Smits, 2022, Journal of the American College of Cardiology.

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial.

Khalid Yusoff, Frederick M. Costello, Martin O'Donnell, 2017, Lancet.

Efficacy and Safety of Ticagrelor Monotherapy by Clinical Presentation: Pre‐Specified Analysis of the GLOBAL LEADERS Trial

P. Serruys, L. Räber, P. Jüni, 2021, Journal of the American Heart Association.

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk.

A. Íñiguez, P. Jüni, S. Windecker, 2021, The New England journal of medicine.

Acute kidney injury in patients with acute coronary syndrome undergoing invasive management treated with bivalirudin vs. unfractionated heparin: insights from the MATRIX trial.

P. Jüni, S. Windecker, M. Valgimigli, 2021, European heart journal. Acute cardiovascular care.

Access-Site Crossover in Patients With Acute Coronary Syndrome Undergoing Invasive Management.

S. Windecker, M. Valgimigli, G. Esposito, 2021, JACC. Cardiovascular interventions.

Ticagrelor monotherapy versus aspirin monotherapy at 12 months after percutaneous coronary intervention: a landmark analysis of the GLOBAL LEADERS trial.

P. Serruys, J. Wykrzykowska, S. Garg, 2022, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Impact of Periprocedural Myocardial Biomarker Elevation on Mortality Following Elective Percutaneous Coronary Intervention.

P. Serruys, S. Silber, S. Windecker, 2019, JACC. Cardiovascular interventions.

Higher risk of stent thrombosis with double therapy with direct oral anticoagulants: cherry picking the populations of interest does not help

A. Goette, M. Valgimigli, P. Vranckx, 2020, European heart journal.

Letter by Vranckx and Valgimigli regarding article, "validation of the bleeding academic research consortium definition of bleeding in patients with coronary artery disease undergoing percutaneous coronary intervention".

M. Valgimigli, P. Vranckx, 2012, Circulation.

The multiplication of loaves and fishes approach: a critic to double anti-thrombotics or to double number of ischaemic events?

C. Cannon, M. Valgimigli, R. Lopes, 2020, European heart journal. Cardiovascular pharmacotherapy.

Acute posterior cerebral circulation syndrome accompanied by serious cardiac rhythm disturbances: A rare but reversible complication following bypass graft angiography

M. Herregods, W. Desmet, H. Heidbüchel, 1999, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Ticagrelor alone or conventional dual antiplatelet therapy in patients with stable or acute coronary syndromes.

P. Serruys, P. Jüni, S. Garg, 2020, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

How should I treat this unusual anterolateral ST-elevation myocardial infarction with recurrent ventricular fibrillation and cardiac arrest?

H. Heidbuchel, M. Noc, M. Valgimigli, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Abbreviated Antiplatelet Therapy After Coronary Stenting in Patients With Myocardial Infarction at High Bleeding Risk.

A. Íñiguez, S. Windecker, M. Valgimigli, 2022, Journal of the American College of Cardiology.

Nitric oxide for inhalation in ST-elevation myocardial infarction (NOMI): a multicentre, double-blind, randomized controlled trial

F. Van de Werf, J. Bogaert, W. Desmet, 2018, European heart journal.

Clinical and Procedural Characteristics Associated With Post-Catheterization Radial Artery Occlusion Early Occlusion Late Occlusion

Sunil V. Rao, F. Burzotta, C. Trani, 2018 .

Development of myocardial infarction

P. Vranckx, 2018, ESC CardioMed.

ischemia during brief coronary artery occlusion in pigs Preoxygenated hemoglobin-based oxygen carrier HBOC-201 annihilates myocardial

Allison R. Schulman, D. Burkhoff, R. Jacobs, 2010 .

Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: Insights from the randomized GLOBAL LEADERS trial.

P. Serruys, J. Tijssen, P. Jüni, 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Clinical benefit of atrio-ventricular delay optimization in patients with a dual-chamber pacemaker: a pilot study. The CBRAVO trial (NCT01998256)

D. Hansen, P. Dendale, P. Vranckx, 2016 .

Clinical benefit of atrio-ventricular delay optimization in patients with a dual-chamber pacemaker: a pilot study.

D. Hansen, P. Dendale, P. Vranckx, 2016, Acta cardiologica.

The ESC Textbook of Intensive and Acute Cardiovascular Care

C. Vrints, P. Vranckx, M. Tubaro, 2014 .

Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR.

C. Hengstenberg, S. Saito, H. Thiele, 2021, The New England journal of medicine.

Acetazolamide for patients with acute decompensated heart failure with volume overload

X. Rosselló, P. Vranckx, V. Menon, 2022, European heart journal. Acute cardiovascular care.

Left main or proximal left anterior descending coronary artery disease location identifies high-risk patients deriving potentially greater benefit from prolonged dual antiplatelet therapy duration.

H. Garcia-Garcia, M. Valgimigli, P. Vranckx, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Two‐year clinical outcomes after successful transcatheter aortic valve implantation with balloon‐expandable versus self‐expanding valves: A subanalysis of the GALILEO trial

J. Tijssen, G. Dangas, S. Windecker, 2022, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Frequency of a positive modified Allen's test in 1,000 consecutive patients undergoing cardiac catheterization.

P. Vranckx, R. Coninx, E. Benit, 1996, Catheterization and cardiovascular diagnosis.

A Critical Appraisal of Aspirin in Secondary Prevention: Is Less More?

S. Windecker, R. Mehran, M. Valgimigli, 2016, Circulation.

How should I treat a cardiac arrest during transcatheter aortic valve implantation?

R. Lange, L. Labrousse, P. Vranckx, 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Retrogade embolization after balloon angioplasty in a patient with late stent subthrombosis in a paclitaxel-eluting stent

P. Vranckx, E. Benit, A. de Wolf, 2008, Acta cardiologica.

Validation of the updated Logistic Clinical SYNTAX score for all-cause mortality in GLOBAL LEADERS trial.

D. van Klaveren, P. Serruys, J. Wykrzykowska, 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Antithrombotic therapy in patients with atrial fibrillation undergoing PCI remains a moving target, yet with a clearer direction!

M. Valgimigli, P. Vranckx, 2022, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

FAME and coronary stent investigations: is there a kink in the wire?

R. Mehran, D. Cutlip, P. Vranckx, 2011, Journal of the American College of Cardiology.

Incidence and multivariable correlates of long-term mortality in patients treated with surgical or percutaneous revascularization in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial.

E. Steyerberg, M. Mack, P. Serruys, 2012, European heart journal.

P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary intervention

Deepak L. Bhatt, Sunil V. Rao, P. Serruys, 2022, Nature Reviews Cardiology.

N on-pharmacologic therapy of acute heart failure : when drugs alone are not enough

P. Vranckx, J. Vijgen, W. Mullens, 2010 .

Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: the Logistic Clinical SYNTAX score.

E. Steyerberg, P. Serruys, L. Räber, 2012, European heart journal.

Should duration of dual antiplatelet therapy depend on the type and/or potency of implanted stent? A pre-specified analysis from the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY (PRODIGY).

R. Ferrari, M. Valgimigli, P. Vranckx, 2013, European heart journal.

A. Goette, L. Eckardt, J. Tijssen, 2019, European heart journal.

Monday, 27 August 2012

V. V. Ivanenko, E. A. Medvedeva, Michail I. Papafaklis, 2012 .

Predicting 2‐year all‐cause mortality after contemporary PCI: Updating the logistic clinical SYNTAX score

D. van Klaveren, E. Steyerberg, P. Serruys, 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions

P. Serruys, M. Krucoff, S. Windecker, 2007, Circulation.

Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium

P. Serruys, M. Krucoff, M. Leon, 2010, European heart journal.

United we stand, divided we fall

C. Hassager, P. Vranckx, S. Price, 2020, European heart journal. Acute cardiovascular care.

[2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.]

Marco Valgimigli, Marco Roffi, Pascal Vranckx, 2018, Kardiologia polska.

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.

M. Mack, P. Serruys, A. Kirtane, 2012, Journal of the American College of Cardiology.

Intensifying Platelet Inhibition With Tirofiban in Poor Responders to Aspirin, Clopidogrel, or Both Agents Undergoing Elective Coronary Intervention: Results From the Double-Blind, Prospective, Randomized Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance

R. Ferrari, M. Valgimigli, G. Campo, 2009, Circulation.

Randomized Tailoring Treatment With Tirofiban in Clopidogrel , or Both Agents Undergoing Elective Coronary Intervention : Results From Intensifying Platelet Inhibition With Tirofiban in Poor Responders to Aspirin

M. Valgimigli, G. Campo, S. Brugaletta, 2009 .

Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices.

H. Thiele, D. Dudek, K. Huber, 2021, European heart journal. Acute cardiovascular care.

The Significance of Drug-Drug and Drug-Food Interactions of Oral Anticoagulation.

H. Heidbuchel, M. Valgimigli, P. Vranckx, 2017, Arrhythmia & electrophysiology review.

Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC).

Deepak L. Bhatt, P. Serruys, G. Stone, 2018, European heart journal.

The ESC Textbook of Intensive and Acute Cardiovascular Care ( 2 ed . )

P. Vranckx, M. Tubaro, S. Price, 2018 .

Evaluation of the safety and efficacy of an edoxaban‐based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST‐AF PCI trial

A. Goette, L. Eckardt, J. Tijssen, 2018, American heart journal.

Atrial Fibrillation on Non-vitamin K Antagonist Oral Anticoagulant Undergoing Elective Percutaneous Coronary Intervention for Stable Effort Angina

H. Heidbuchel, M. Valgimigli, P. Vranckx, 2017 .

Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial

A. Huber, L. Räber, M. Valgimigli, 2021, Circulation.

Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease

Deepak L. Bhatt, J. Eikelboom, R. Mehran, 2020, Nature Reviews Cardiology.

Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention

Deepak L. Bhatt, P. Serruys, G. Dangas, 2018, Nature Reviews Cardiology.

Duration of Antiplatelet Therapy After Complex Percutaneous Coronary Intervention In Patients at High Bleeding Risk: a MASTER DAPT trial sub-analysis.

M. Valgimigli, P. Smits, D. Heg, 2022, European heart journal.

3- or 1-Month DAPT in Patients at High Bleeding Risk Undergoing Everolimus-Eluting Stent Implantation.

Deepak L. Bhatt, S. Saito, H. Thiele, 2021, JACC. Cardiovascular interventions.

Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention?: A Pre-Specified Analysis From the ZEUS Trial.

M. Valgimigli, M. Roffi, C. Briguori, 2016, JACC. Cardiovascular interventions.

Predicting medical usage rate at mass gathering events in Belgium: development and validation of a nonlinear multivariable regression model

P. Vranckx, H. Scheers, H. Van Remoortel, 2022, BMC Public Health.

Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document

J. Spertus, P. Serruys, G. Stone, 2018, Circulation.

5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions.

Antonio Colombo, Pascal Vranckx, Patrick W Serruys, 2010, Journal of the American College of Cardiology.

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.

M. Mack, P. Serruys, A. Kirtane, 2012, The Journal of thoracic and cardiovascular surgery.

Prospective validation of the Bleeding Academic Research Consortium classification in the all-comer PRODIGY trial.

R. Mehran, M. Valgimigli, P. Vranckx, 2014, European heart journal.

Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial

P. Serruys, L. Mauri, E. Boersma, 2012, The Lancet.

Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document

J. Spertus, P. Serruys, G. Stone, 2018, European heart journal.

Contemporary mortality differences between primary percutaneous coronary intervention and thrombolysis in ST-segment elevation myocardial infarction.

C. Vrints, P. Sinnaeve, P. Vranckx, 2011, Archives of internal medicine.

Clinical outcomes after zotarolimus and everolimus drug eluting stent implantation in coronary artery bifurcation lesions: insights from the RESOLUTE All Comers Trial

P. Serruys, S. Silber, J. Wykrzykowska, 2013, Heart.

External validation of the GRACE risk score 2.0 in the contemporary all‐comers GLOBAL LEADERS trial

P. Serruys, S. Windecker, M. Valgimigli, 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Interventional Cardiology Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting A Randomized Multicenter Trial

J. Marchesini, R. Ferrari, M. Valgimigli, 2015 .

Usefulness of percutaneous left ventricular assistance to support high-risk percutaneous coronary interventions.

P. Serruys, J. Ottervanger, Chi‐Hang Lee, 2003, The American journal of cardiology.

Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial

P. Serruys, S. Silber, S. Windecker, 2011, The Lancet.

Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 2: Endpoint Definitions: A Consensus Document From the Mitral Valve Academic Research Consortium.

G. Filippatos, D. Adams, G. Stone, 2015, Journal of the American College of Cardiology.

Neuromuscular electrical stimulation increases muscle protein synthesis in elderly type 2 diabetic men.

L. V. van Loon, M. Dirks, B. Wall, 2012, American journal of physiology. Endocrinology and metabolism.

Assisted circulation using the TandemHeart® during very high‐risk PCI of the unprotected left main coronary artery in patients declined for CABG

P. Serruys, M. Valgimigli, R. V. van Domburg, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Critical Appraisal of Contemporary Clinical Endpoint Definitions in Coronary Intervention Trials: A Guidance Document.

Jonathan H Seltzer, C. Held, P. Serruys, 2019, JACC. Cardiovascular interventions.

Assisted circulation using the Tandemhear , percutaneous transseptal left ventricular assist device, during percutaneous aortic valve implantation: the Rotterdam experience.

P. Serruys, R. V. van Domburg, P. Vranckx, 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

The impact of pre-procedure heart rate on adverse clinical outcomes in patients undergoing percutaneous coronary intervention: Results from a 2-year follow-up of the GLOBAL LEADERS trial.

P. Serruys, S. Garg, S. Windecker, 2020, Atherosclerosis.

Respiratory management in severe acute respiratory syndrome coronavirus 2 infection

M. Hind, P. Vranckx, S. Price, 2020, European heart journal. Acute cardiovascular care.

Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplas

J. Marchesini, M. Valgimigli, G. Campo, 2014, JACC. Cardiovascular interventions.

5-Year follow-up of coronary revascularization in diabetic patients with multivessel coronary artery disease: insights from ARTS (arterial revascularization therapy study)-II and ARTS-I trials.

P. Serruys, J. Wykrzykowska, S. Garg, 2011, JACC. Cardiovascular interventions.

Association of diabetes with outcomes in patients undergoing contemporary percutaneous coronary intervention: Pre-specified subgroup analysis from the randomized GLOBAL LEADERS study.

P. Serruys, A. Íñiguez, J. Wykrzykowska, 2020, Atherosclerosis.

Ascertainment of Silent Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention (from the GLOBAL LEADERS Trial).

P. Serruys, S. Windecker, M. Valgimigli, 2019, The American journal of cardiology.

Non-vitamin K oral anticoagulants in patients with atrial fibrillation after cardiac surgery: the results of the European Heart Rhythm Association Survey.

H. Heidbuchel, T. Potpara, N. Dagres, 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Prediction of radial crossover in acute coronary syndromes: derivation and validation of the MATRIX score.

D. van Klaveren, E. Romagnoli, G. Biondi-Zoccai, 2021, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.

M. Mack, P. Serruys, A. Kirtane, 2012, European heart journal.

Echocardiography and thoracic ultrasound-Oxford Medicine

P. Vranckx, M. Tubaro, S. Price, 2018 .

HBOC-201: the multi-purpose oxygen therapeutic.

A. Greenburg, P. Vranckx, G. Dubé, 2008, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Abbreviated or Standard Antiplatelet Therapy in HBR Patients: Final 15-Month Results of the MASTER-DAPT Trial.

S. Cook, S. Windecker, M. Valgimigli, 2023, JACC. Cardiovascular interventions.

Reperfusion therapy and mortality in octogenarian STEMI patients: results from the Belgian STEMI registry

P. Sinnaeve, P. Vranckx, M. Claeys, 2013, Clinical Research in Cardiology.

Regional variation in patients and outcomes in the GLOBAL LEADERS trial.

P. Serruys, S. Garg, S. Windecker, 2020, International journal of cardiology.

Usefulness of updated logistic clinical SYNTAX score based on MI‐SYNTAX score in patients with ST‐elevation myocardial infarction

P. Serruys, H. Suryapranata, R. D. de Winter, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Impact of Preprocedural Computed Tomography on Left Atrial Appendage Closure Success: A Swiss-Apero Trial Subanalysis.

A. Huber, L. Räber, M. Valgimigli, 2023, JACC. Cardiovascular interventions.

A global risk approach to identify patients with left main or 3-vessel disease who could safely and efficaciously be treated with percutaneous coronary intervention: the SYNTAX Trial at 3 years.

E. Steyerberg, M. Mack, P. Serruys, 2012, JACC: Cardiovascular Interventions.

Association of acute kidney injury and bleeding events with mortality after radial or femoral access in patients with acute coronary syndrome undergoing invasive management: secondary analysis of a randomized clinical trial

E. Romagnoli, M. Valgimigli, F. Amico, 2019, European heart journal.

Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug‐Eluting Stent Implantation: Per‐Protocol Analysis of the GLOBAL LEADERS Trial

M. Zwahlen, P. Serruys, S. Windecker, 2022, Journal of the American Heart Association.

Comparison of Investigator-Reported and Clinical Event Committee-Adjudicated Outcome Events in GLASSY.

P. Serruys, S. Garg, S. Windecker, 2021, Circulation. Cardiovascular quality and outcomes.

Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY)

P. Serruys, S. Garg, S. Windecker, 2019, BMJ Open.

Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 2: endpoint definitions: A consensus document from the Mitral Valve Academic Research Consortium.

G. Filippatos, D. Adams, G. Stone, 2015, European heart journal.

Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials.

Deepak L. Bhatt, G. Stone, S. Windecker, 2022, European heart journal.

Dual antiplatelet therapy duration after percutaneous coronary intervention in patients with indication to oral anticoagulant therapy. A systematic review and meta-analysis of randomized controlled trials.

M. Valgimigli, R. Lopes, D. Capodanno, 2022, European heart journal. Cardiovascular pharmacotherapy.

PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSY.

P. Serruys, S. Garg, S. Windecker, 2020, European heart journal. Cardiovascular pharmacotherapy.

Impact of overlapping newer generation drug-eluting stents on clinical and angiographic outcomes: pooled analysis of five trials from the international Global RESOLUTE Program

A. Yeung, P. Serruys, S. Silber, 2013, Heart.

The ABC and D of cardiac resuscitation in the cath lab

P. Vranckx, E. Benit, 2006 .

Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium

Deepak L. Bhatt, P. Serruys, M. Krucoff, 2023, Circulation.

Adherence to quality indicators for ST-elevation myocardial infarction and its relation to mortality: a hospital network analysis from the Belgian STEMI database.

P. Sinnaeve, P. Vranckx, M. Claeys, 2020, European heart journal. Quality of care & clinical outcomes.

STEMI mortality in community hospitals versus PCI-capable hospitals: results from a nationwide STEMI network programme

C. Vrints, P. Sinnaeve, P. Vranckx, 2012, European heart journal. Acute cardiovascular care.

P2Y12 Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions.

P. Serruys, G. Dangas, S. Windecker, 2023, Journal of the American College of Cardiology.

Haemodynamic effects, safety, and tolerability of haemoglobin-based oxygen carrier-201 in patients undergoing PCI for CAD.

P. Serruys, R. D. de Winter, G. Schuler, 2008, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

PREDICTIVE ABILITY OF THE PARIS RISK SCORE IN ALL-COMERS PATIENTS UNDERGOING PCI WITH DRUG ELUTING STENTS: EXTERNAL VALIDATION IN THE GLOBAL LEADERS STUDY

T. Seidler, P. Serruys, S. Windecker, 2019, Journal of the American College of Cardiology.

Preoxygenated hemoglobin-based oxygen carrier HBOC-201 annihilates myocardial ischemia during brief coronary artery occlusion in pigs.

P. Serruys, E. Regar, W. J. van der Giessen, 2010, American journal of physiology. Heart and circulatory physiology.

Biodegradable-polymer-based, paclitaxel-eluting Infinnium stent: 9-Month clinical and angiographic follow-up results from the SIMPLE II prospective multi-centre registry study.

P. Serruys, E. Ribeiro, P. Lemos, 2006, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Biolimus-eluting vs. other limus-eluting stents in NSTE-ACS: A pooled analysis of glassy and twilight.

A. Kastrati, G. Dangas, S. Windecker, 2023, International journal of cardiology.

A patient-level pooled analysis assessing the impact of the SYNTAX (synergy between percutaneous coronary intervention with taxus and cardiac surgery) score on 1-year clinical outcomes in 6,508 patients enrolled in contemporary coronary stent trials.

P. Serruys, L. Räber, S. Garg, 2011, JACC. Cardiovascular interventions.

Impact of Ticagrelor Monotherapy on Two-Year Clinical Outcomes in Patients with Long Stenting: A Post Hoc Analysis of the Global Leaders Trial.

P. Serruys, J. Tijssen, R. D. de Winter, 2020, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

P2812Ischemic efficacy and bleeding safety of ticagrelor monotherapy in patients with multivessel percutaneous coronary intervention: insights from the Global Leaders trial

P. Serruys, S. Windecker, M. Valgimigli, 2019, European Heart Journal.

Predictive ability of ACEF and ACEF II score in patients undergoing percutaneous coronary intervention in the GLOBAL LEADERS study.

D. van Klaveren, P. Serruys, J. Wykrzykowska, 2019, International journal of cardiology.

Cardiovascular risk profile of patients included in stent trials; a pooled analysis of individual patient data from randomised clinical trials: insights from 33 prospective stent trials in Europe.

Dick M. Goedhart, P. Serruys, S. Garg, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

The cinical sigInifcance ofv wole bloo viscosity in ( cardio ) vascular medicine

C. Slager, P. Vranckx, D. Duncker, 2022 .

Mode of admission and its effect on adherence to reperfusion therapy guidelines in Belgian STEMI patients

P. Sinnaeve, P. Vranckx, M. Claeys, 2016, European heart journal. Acute cardiovascular care.

The clinical significance of whole blood viscosity in (cardio)vascular medicine.

C. Slager, P. Vranckx, D. Duncker, 2002, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Gender, TIMI risk score and in-hospital mortality in STEMI patients undergoing primary PCI: results from the Belgian STEMI registry.

D. De Bacquer, P. Sinnaeve, P. Vranckx, 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Physical fitness affects the quality of single operator cardiocerebral resuscitation in healthcare professionals

D. Hansen, P. Dendale, P. Vranckx, 2012, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.

G. Hindricks, F. Crea, A. Kastrati, 2017, Revista espanola de cardiologia.

Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease: 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), Association for Acute CardioVascular Care (ACVC) and European Association of Pr

D. Atar, V. Aboyans, S. Windecker, 2023, European Heart Journal - Cardiovascular Pharmacotherapy.

2023 ESC Guidelines for the management of acute coronary syndromes.

B. Lewis, S. Antoniou, L. Fauchier, 2023, European heart journal.

G. Hindricks, F. Crea, A. Kastrati, 2018, European heart journal.

Assisted circulation using the Tandemheart®, percutaneous transseptal left ventricular assist device, during percutaneous aortic valve implantation: The Rotterdam experience

P. Serruys, P. Vranckx, C. Schultz, 2009 .

Inter-hospital variation in length of hospital stay after ST-elevation myocardial infarction: results from the Belgian STEMI registry

C. Vrints, P. Sinnaeve, P. Vranckx, 2013 .

BIOVASC Trial in Perspective: Complete Revascularization Strategies in Patients Presenting With Acute Coronary Syndromes and Multivessel Coronary Disease.

P. Vranckx, S. van Diepen, 2023, European heart journal. Acute cardiovascular care.

Dyspnoea in the GLOBAL LEADERS trial – Authors' reply

P. Serruys, S. Windecker, P. Vranckx, 2019, The Lancet.

Three-year follow-up of the ARTS-II# - sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease.

P. Serruys, R. V. van Domburg, M. Morice, 2008, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Evaluation of the safety and efficacy of an edoxaban-based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention ( PCI ) with stent placement : Rationale and design of the ENTRUST-AF PCI trial

J. Tijssen, M. Valgimigli, P. Vranckx, 2018 .

Third universal definition of myocardial infarction

Jeroen J. Bax, P. Kirchhof, D. Atar, 2013, Nature Reviews Cardiology.

Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices.

H. Thiele, D. Dudek, K. Huber, 2021, EuroIntervention.

Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices

V. Kunadian, P. Vranckx, G. Tarantini, 2021 .

Symbols and abbreviations

Pascal Vranckx, Gerasimos Filippatos, Nicolas Danchin, 2010 .

Management of Bleeding and Hemolysis During Percutaneous Microaxial Flow Pump Support: A Practical Approach.

A. Mebazaa, G. Stone, A. Scandroglio, 2023, JACC. Cardiovascular interventions.

Third universal definition of myocardial infarction.

Jeroen J. Bax, P. Kirchhof, D. Atar, 2012, Journal of the American College of Cardiology.

2023 ESC Guidelines for the management of acute coronary syndromes.

L. Fauchier, L. Neubeck, L. Räber, 2023, European heart journal. Acute cardiovascular care.

Inter-hospital variation in length of hospital stay after ST-elevation myocardial infarction: results from the Belgian STEMI registry.

C. Vrints, P. Sinnaeve, P. Vranckx, 2013, Acta cardiologica.

Third universal definition of myocardial infarction.

Jeroen J. Bax, D. Atar, P. Kolh, 2012, European heart journal.

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2).

M. Mack, P. Serruys, A. Kirtane, 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes.

M. Valgimigli, C. Briguori, E. Omerovic, 2015, The New England journal of medicine.

Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial

M. Valgimigli, A. Santarelli, C. Briguori, 2015, The Lancet.

R. Ferrari, M. Valgimigli, G. Campo, 2009, Circulation.

Darapladib effect on circulating high sensitive troponin in patients with acute coronary syndromes.

P. Serruys, H. Garcia-Garcia, E. Boersma, 2012, Atherosclerosis.

A global risk approach to identify patients with left main or 3-vessel disease who could safely and efficaciously be treated with percutaneous coronary intervention: the SYNTAX Trial at 3 years.

E. Steyerberg, M. Mack, P. Serruys, 2012, JACC. Cardiovascular interventions.

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.

S. Windecker, T. Brott, R. Mehran, 2012, The Journal of thoracic and cardiovascular surgery.

Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting: A Randomized Multicenter Trial

J. Marchesini, R. Ferrari, M. Valgimigli, 2012, Circulation.

R. Ferrari, M. Valgimigli, P. Vranckx, 2013, European heart journal.

Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review.

Deepak L. Bhatt, B. Gersh, C. Cannon, 2019, Journal of the American College of Cardiology.

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.

S. Windecker, T. Brott, R. Mehran, 2012, European heart journal.

Clinical outcomes after zotarolimus and everolimus drug eluting stent implantation in coronary artery bifurcation lesions: insights from the RESOLUTE All Comers Trial

P. Serruys, S. Silber, J. Wykrzykowska, 2013, Heart.

1- or 3-Month DAPT in Patients With HBR With or Without Oral Anticoagulant Therapy After PCI.

S. Bangalore, B. Vogel, S. Sartori, 2023, JACC. Cardiovascular interventions.

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.

S. Windecker, R. Mehran, D. Cutlip, 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Proof-of-concept trial to evaluate haemoglobin based oxygen therapeutics in elective percutaneous coronary revascularisation. Rationale, protocol design and haemodynamic results.

P. Serruys, E. Regar, P. Vranckx, 2008, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Edoxaban and/or colchicine in outpatients with COVID-19: rationale and design of the CONVINCE trial

P. Vranckx, M. Tresoldi, N. Morici, 2023, Journal of cardiovascular medicine.

Physical manoeuvers as a preventive intervention to manage vasovagal syncope: A systematic review

K. Dockx, P. Vranckx, B. Avau, 2019, PloS one.

Airborne Transmission

J. Minei, B. Bechtel, P. Vranckx, 2020, Definitions.

Left main or proximal left anterior descending coronary artery disease location identifies high-risk patients deriving potentially greater benefit from prolonged dual antiplatelet therapy duration.

H. Garcia-Garcia, M. Valgimigli, P. Vranckx, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Systematic Review and Patient-Level Meta-Analysis.

G. Dangas, D. Angiolillo, D. Heg, 2024, JAMA cardiology.

De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials

G. Dangas, R. Mehran, U. Baber, 2024, The Lancet.

Demystifying the Contemporary Role of 12-Month Dual Antiplatelet Therapy After Acute Coronary Syndrome.

D. Angiolillo, D. Sibbing, P. Vranckx, 2024, Circulation.

Quality assessment in Belgian ST elevation myocardial infarction patients: results from the Belgian STEMI database

P. Sinnaeve, P. Vranckx, M. Claeys, 2018, Acta cardiologica.

Alcohol intoxication.

J. Minei, B. Bechtel, P. Vranckx, 1998, Journal of accident & emergency medicine.